High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
Clinical trial NCT00080977 · UNKNOWN
Trial details
- NCT number
- NCT00080977
- Sponsor
- Blumenthal Cancer Center at Carolinas Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.